• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸西拉米辛的固体形态对其在水性环境中行为的影响。

Influence of the solid form of siramesine hydrochloride on its behavior in aqueous environments.

作者信息

Zimmermann Anne, Tian Fang, Lopez de Diego Heidi, Ringkjøbing Elema Michiel, Rantanen Jukka, Müllertz Anette, Hovgaard Lars

机构信息

Faculty of Pharmaceutical Sciences, Department of Pharmaceutics and Analytical Chemistry, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen Ø, Denmark.

出版信息

Pharm Res. 2009 Apr;26(4):846-54. doi: 10.1007/s11095-008-9783-0. Epub 2008 Nov 13.

DOI:10.1007/s11095-008-9783-0
PMID:19005740
Abstract

PURPOSE

To study the influence of solid form on the behavior of the salt siramesine hydrochloride in aqueous environments.

METHODS

The solubilities and dissolution rates of siramesine hydrochloride anhydrate and monohydrate were determined at pH 3.4 and 6.4, and precipitates were examined by X-ray powder diffraction. The mechanism of anhydrate-hydrate conversion was investigated by optical microscopy, and wet massing of the anhydrate was carried out using water and 60% (v/v) ethanol separately as granulation liquids. The wet masses were analyzed using Raman microscopy.

RESULTS

At pH 3.4 the anhydrate and monohydrate salts exhibited similar dissolution profiles. At pH 6.4 both the anhydrate and monohydrate salts formed supersaturated solutions of high apparent solubility. From the anhydrate solution, precipitation of the free base occurred, while the solution of the monohydrate salt remained in the supersaturated state. This resulted in a superior dissolution profile of the monohydrate salt. Microscopy and wet massing experiments showed that the anhydrate-hydrate conversion of siramesine hydrochloride was solution-mediated and dissolution-controlled.

CONCLUSION

During development of a formulation based on the anhydrate salt, the risk of processing-induced transformation to the monohydrate form as well as precipitation of the free base should be considered.

摘要

目的

研究固体形态对盐酸西拉米辛在水性环境中行为的影响。

方法

测定了无水盐酸西拉米辛和一水合盐酸西拉米辛在pH 3.4和6.4时的溶解度和溶解速率,并用X射线粉末衍射对沉淀物进行了检测。通过光学显微镜研究了无水物 - 水合物转化的机理,并分别用水和60%(v/v)乙醇作为制粒液对无水物进行了湿法制粒。使用拉曼显微镜对湿颗粒进行了分析。

结果

在pH 3.4时,无水盐和一水合盐表现出相似的溶解曲线。在pH 6.4时,无水盐和一水合盐均形成了具有高表观溶解度的过饱和溶液。从无水物溶液中,游离碱发生沉淀,而一水合盐溶液保持过饱和状态。这导致一水合盐具有更好的溶解曲线。显微镜和湿法制粒实验表明,盐酸西拉米辛的无水物 - 水合物转化是由溶液介导且受溶解控制的。

结论

在基于无水盐开发制剂的过程中,应考虑加工过程中转化为一水合物形式以及游离碱沉淀的风险。

相似文献

1
Influence of the solid form of siramesine hydrochloride on its behavior in aqueous environments.盐酸西拉米辛的固体形态对其在水性环境中行为的影响。
Pharm Res. 2009 Apr;26(4):846-54. doi: 10.1007/s11095-008-9783-0. Epub 2008 Nov 13.
2
Structural characterisation and dehydration behaviour of siramesine hydrochloride.盐酸西拉美汀的结构特征和脱水行为。
J Pharm Sci. 2009 Oct;98(10):3596-607. doi: 10.1002/jps.21679.
3
Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients.通过更好地理解药用辅料的作用来控制高剪切湿法制粒过程中茶碱一水合物的形成。
Pharm Res. 2008 Apr;25(4):923-35. doi: 10.1007/s11095-007-9450-x. Epub 2007 Sep 26.
4
Roller compaction of different pseudopolymorphic forms of theophylline: Effect on compressibility and tablet properties.不同茶碱假多晶型形式的滚压压实:对可压缩性和片剂性质的影响。
Int J Pharm. 2010 Aug 30;396(1-2):53-62. doi: 10.1016/j.ijpharm.2010.06.009. Epub 2010 Jun 19.
5
Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms.洞悉吡罗昔康无水物和一水合物形式的溶解度和溶解行为。
Int J Pharm. 2012 Jul 15;431(1-2):111-9. doi: 10.1016/j.ijpharm.2012.04.042. Epub 2012 Apr 23.
6
Solid-state properties and relationship between anhydrate and monohydrate of baclofen.巴氯芬的固态性质以及无水物与一水合物之间的关系。
J Pharm Sci. 2007 Sep;96(9):2399-408. doi: 10.1002/jps.20894.
7
Phase transformations of amlodipine besylate solid forms.苯磺酸氨氯地平固体形式的相转变。
J Pharm Sci. 2011 Jul;100(7):2896-910. doi: 10.1002/jps.22509. Epub 2011 Feb 22.
8
In situ measurement of solvent-mediated phase transformations during dissolution testing.溶出度测试过程中溶剂介导的相变的原位测量。
J Pharm Sci. 2006 Dec;95(12):2730-7. doi: 10.1002/jps.20725.
9
Structural elucidation of rapid solution-mediated phase transitions in pharmaceutical solids using in situ synchrotron SAXS/WAXS.利用同步辐射小角 X 射线散射/广角 X 射线散射技术对药物固体中快速溶液介导的相转变进行结构解析。
Mol Pharm. 2012 Sep 4;9(9):2787-91. doi: 10.1021/mp3003072. Epub 2012 Aug 14.
10
Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug.溶液中盐的介稳相转变:以氟哌啶醇为模型药物的研究。
J Pharm Sci. 2011 Jul;100(7):2755-68. doi: 10.1002/jps.22507. Epub 2011 Feb 16.

本文引用的文献

1
Salt formation to improve drug solubility.通过盐形成来提高药物溶解度。
Adv Drug Deliv Rev. 2007 Jul 30;59(7):603-16. doi: 10.1016/j.addr.2007.05.010. Epub 2007 May 29.
2
Solubility: it's not just for physical chemists.溶解度:它不仅仅关乎物理化学家。
Drug Discov Today. 2006 Nov;11(21-22):1012-8. doi: 10.1016/j.drudis.2006.09.002. Epub 2006 Sep 26.
3
In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy.使用拉曼光谱法在线监测湿法制粒过程中的水合物形成。
J Pharm Sci. 2005 Jan;94(1):209-19. doi: 10.1002/jps.20241.
4
Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols.中链和长链三酰甘油体外脂解过程中难溶性药物的增溶作用。
Eur J Pharm Sci. 2004 Nov;23(3):287-96. doi: 10.1016/j.ejps.2004.08.003.
5
Influence of processing-induced phase transformations on the dissolution of theophylline tablets.加工诱导相变对茶碱片溶出度的影响。
AAPS PharmSciTech. 2004 Feb 12;5(1):E8. doi: 10.1208/pt050108.
6
Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations.通过过饱和制剂提高难溶性药物PNU-91325的口服生物利用度。
Drug Dev Ind Pharm. 2004 Feb;30(2):221-9. doi: 10.1081/ddc-120028718.
7
Evaluation of drug physical form during granulation, tabletting and storage.制粒、压片及储存过程中药物物理形态的评估。
Int J Pharm. 2004 May 4;275(1-2):29-39. doi: 10.1016/j.ijpharm.2004.01.042.
8
Pharmaceutical evaluation of early development candidates "the 100 mg-approach".早期研发候选药物的药学评估 “100毫克方法”
Int J Pharm. 2004 May 4;275(1-2):1-12. doi: 10.1016/j.ijpharm.2004.01.034.
9
DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS.某些药物的结晶溶剂化物和非溶剂化物形式的溶解行为
J Pharm Sci. 1963 Aug;52:781-91. doi: 10.1002/jps.2600520815.
10
Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis.
Pharm Res. 2002 Sep;19(9):1285-91. doi: 10.1023/a:1020621906855.